Amiloride hydrochloride; hydrochlorothiazide - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for amiloride hydrochloride; hydrochlorothiazide and what is the scope of patent protection?
Amiloride hydrochloride; hydrochlorothiazide
is the generic ingredient in three branded drugs marketed by Barr, Chartwell Rx, Rising, Teva, Watson Labs, Par Pharm, and Merck, and is included in seven NDAs. Additional information is available in the individual branded drug profile pages.Two suppliers are listed for this compound.
Summary for amiloride hydrochloride; hydrochlorothiazide
| US Patents: | 0 |
| Tradenames: | 3 |
| Applicants: | 7 |
| NDAs: | 7 |
| Finished Product Suppliers / Packagers: | 2 |
| Clinical Trials: | 12 |
| DailyMed Link: | amiloride hydrochloride; hydrochlorothiazide at DailyMed |
Recent Clinical Trials for amiloride hydrochloride; hydrochlorothiazide
Identify potential brand extensions & 505(b)(2) entrants
| Sponsor | Phase |
|---|---|
| Hospital de Clinicas de Porto Alegre | Phase 3 |
| Instituto de Cardiologia do Rio Grande do Sul | Phase 3 |
| Guangdong Provincial People's Hospital | Phase 4 |
See all amiloride hydrochloride; hydrochlorothiazide clinical trials
Pharmacology for amiloride hydrochloride; hydrochlorothiazide
| Drug Class | Potassium-sparing Diuretic Thiazide Diuretic |
| Physiological Effect | Decreased Renal K+ Excretion Increased Diuresis |
Anatomical Therapeutic Chemical (ATC) Classes for amiloride hydrochloride; hydrochlorothiazide
US Patents and Regulatory Information for amiloride hydrochloride; hydrochlorothiazide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Merck | MODURETIC 5-50 | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 018201-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Barr | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 071111-001 | May 10, 1988 | AB | RX | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | |||
| Watson Labs | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 073334-001 | Jul 19, 1991 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| Teva | AMILORIDE HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 070795-001 | Apr 17, 1988 | DISCN | No | No | ⤷ Sign Up | ⤷ Sign Up | ⤷ Sign Up | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for amiloride hydrochloride; hydrochlorothiazide
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
|---|---|---|---|---|---|---|---|
| Merck | MODURETIC 5-50 | amiloride hydrochloride; hydrochlorothiazide | TABLET;ORAL | 018201-001 | Approved Prior to Jan 1, 1982 | ⤷ Sign Up | ⤷ Sign Up |
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Major Patent Expirations 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Follow DrugPatentWatch:
